Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection

Human Immunology

Volumn 72, Issue 11, 2011, Pages 1068-1073

  Shi, Wei Wu ^a   Lin, Aifen ^a   Xu, Dan Ping ^a   Bao, Wei Guang ^a   Zhang, Jian Gang ^a   Chen, Shi Yong ^a   Li, Jun ^a   Yan, Wei Hua ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Hepatitis B virus; HLA G; Infection

Indexed keywords

CD14 ANTIGEN; CELL SURFACE PROTEIN; HLA G ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ACUTE HEPATITIS; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL COUNT; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HLA-G ANTIGENS; HUMANS; IMMUNE EVASION; MALE; MIDDLE AGED; MONOCYTES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 80054108228     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.06.012     Document Type: Article

References (41)

1. Ganem D., Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
2. Kao J.H., Chen D.S. Global control of hepatitis B virus infection. Lancet Infect Dis 2002, 2:395-403.
3. Kao J.H. Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol 2008, 2:553-562.
4. Elgouhari H.M., Abu-Rajab Tamimi T.I., Carey W.D. Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis. Cleve Clin J Med 2008, 75:881-889.
5. Carosella E.D., Moreau P., Le Maoult J., Le Discorde M., Dausset J., Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003, 81:199-252.
6. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalil-Daher I., Vazeux G., et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000, 61:1138-1149.
7. Rebmann V., Busemann A., Lindemann M., Grosse-Wilde H. Detection of HLA-G5 secreting cells. Hum Immunol 2003, 64:1017-1024.
8. Hofmeister V., Weiss E.H. HLA-G modulates immune responses by diverse receptor interactions. Semin Cancer Biol 2003, 13:317-323.
9. Carosella E.D., Moreau P., Lemaoult J., Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008, 29:125-132.
10. Chen H.X., Chen B.G., Shi W.W., Zhen R., Xu D.P., Lin A., et al. Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients. Hum Immunol 2011, 72:159-165.
11. Yan W.H., Lin A., Chen B.G., Chen S.Y. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis 2009, 200:820-826.
12. Donaghy L., Gros F., Amiot L., Mary C., Maillard A., Guiguen C., et al. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clin Exp Immunol 2007, 147:236-240.
13. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005, 79:15226-15237.
14. Souto F.J., Crispim J.C., Ferreira S.C., et al. Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection. J Viral Hepat 2011, 18:102-105.
15. Shih IeM. Application of human leukocyte antigen-G expression in the diagnosis of human cancer. Hum Immunol 2007, 68:272-276.
16. Singer G., Rebmann V., Chen Y.C., Liu H.T., Ali S.Z., Reinsberg J., et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003, 9:4460-4464.
17. Monneret G., Voirin N., Krawice-Radanne I., Bohê J., Lepape A., Rouas-Freiss N., et al. Soluble human leukocyte antigen-G5 in septic shock: marked and persisting elevation as a predictor of survival. Crit Care Med 2007, 35:1942-1947.
18. National program for prevention and treatment of viral hepatitis. Chin J Hepatol 2000, 8:324-329. Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.
19. McMahon B.J. The natural history of chronic hepatitis B virus infection. Hepatology 2009, 49:S45-S55.
20. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2007, 45:507-539.
21. Onno M., Pangault C., Le Friec G., Guilloux V., Andrê P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000, 164:6426-6434.
22. Barel M.T., Ressing M., Pizzato N., van Leeuwen D., Le Bouteiller P., Lenfant F., et al. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J Immunol 2003, 171:6757-6765.
23. Lozano J.M., GonzÂlez R., KindelÂn J.M., et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002, 16:347-351.
24. Mêgret F., Prehaud C., Lafage M., et al. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum Immunol 2007, 68:294-302.
25. Jung M.C., Pape G.R. Immunology of hepatitis B infection. Lancet Infect Dis 2002, 2:43-50.
26. Carosella E.D., HoWangYin K.Y., Favier B., LeMaoult J. HLA-G-dependent suppressor cells: diverse by nature, function, and significance. Hum Immunol 2008, 69:700-707.
27. Chung M.K., Yoon H., Min S.S., et al. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen. J Immunother 1999, 22:279-287.
28. LÖhr H.F., Gerken G., Schlicht H.J., Meryer zum BÜschenfelde K.H., Fleischer B. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis 1993, 168:1133-1139.
29. Fainardi E., Rizzo R., Castellazzi M., Stignani M., Granieri E., Baricordi O.R. Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis. Hum Immunol 2009, 70:981-987.
30. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003, 33:125-134.
31. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000, 164:6100-6104.
32. Jung M.C., Spengler U., Schraut W., Hoffmann R., Zachoval R., Eisenburg J., et al. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol 1991, 13:310-317.
33. Ferrari C., Penna A., Bertoletti A., Valli A., Antoni A.D., Giuberti T., et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990, 145:3442-3449.
34. Le Maux A., Noël G., Birebent B., Grosset J.M., Vu N., De Guibert S., et al. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells. Clin Exp Immunol 2008, 152:50-56.
35. + regulatory T cells. Stem Cells 2008, 26:212-222.
36. Barrier B.F., Kendall B.S., Sharpe-Timms K.L., Kost E.R. Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol 2006, 103:25-30.
37. Gan L.H., Huang L.F., Zhang X., Lin A., Xu D.P., Wang Q., et al. Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma. Hum Immunol 2010, 71:899-904.
38. Li B.L., Lin A., Zhang X.J., Zhang X., Zhang J.G., Wang Q., et al. Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens 2009, 74:213-221.
39. Chen H.X., Lin A., Shen C.J., Zhen R., Chen B.G., Zhang X., et al. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer. Hum Immunol 2010, 71:892-898.
40. Zhu C.B., Wang C.X., Zhang X., Zhang J., Li W. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases. Int J Cancer 2011, 128:617-622.
41. Lin A, Zhang X, Zhou WJ, Ruan YY, Xu DP, Wang Q, et al. HLA-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Cancer.